2V7A | B:242-493; B:242-493 | CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358 |
3QRI | B:242-493; B:242-493 | THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC-2036 |
3QRJ | B:242-493; B:242-493 | THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036 |
3QRK | A:242-493 | THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP-987 |
2XYN | C:288-539; C:288-539; C:288-539 | HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680 |
1U46 | B:126-385; B:126-385 | CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1 |
1U4D | B:126-385; B:126-385 | STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE |
1U54 | B:126-385; B:126-385 | CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP |
2XB7 | A:1116-1383 | STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684 |
2XBA | A:1116-1383 | STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429 |
2YHV | A:1116-1383 | STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE |
3L9P | A:1116-1383 | CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
3LCS | A:1116-1383 | CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
3LCT | A:1116-1383 | CRYSTAL STRUCTURE OF THE ANAPLASTIC LYMPHOMA KINASE CATALYTIC DOMAIN |
2XP2 | A:1116-1383 | STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066) |
2YFX | A:1116-1383 | STRUCTURE OF L1196M MUTANT ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB |
1UWH | B:456-713; B:456-713 | THE COMPLEX OF WILD TYPE B-RAF AND BAY439006 |
3PPJ | B:457-714; B:457-714 | HUMAN B-RAF KINASE IN COMPLEX WITH A FUROPYRIDINE INHIBITOR |
3PPK | B:457-714; B:457-714 | HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR |
3PRF | B:457-714; B:457-714 | CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR |
3PRI | B:457-714; B:457-714 | CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR |
3PSB | B:457-714; B:457-714 | FURO[2,3-C]PYRIDINE-BASED INDANONE OXIMES AS POTENT AND SELECTIVE B-RAF INHIBITORS |
3PSD | B:457-714; B:457-714 | NON-OXIME PYRAZOLE BASED INHIBITORS OF B-RAF KINASE |
3Q4C | B:456-713; B:456-713 | CRYSTAL STRUCTURE OF WILD TYPE BRAF KINASE DOMAIN IN COMPLEX WITH ORGANOMETALLIC INHIBITOR CNS292 |
3Q96 | B:457-714; B:457-714 | B-RAF KINASE DOMAIN IN COMPLEX WITH A TETRAHYDRONAPHTHALENE INHIBITOR |
1K2P | B:402-651; B:402-651 | CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN |
3K54 | A:402-651 | STRUCTURES OF HUMAN BRUTON'S TYROSINE KINASE IN ACTIVE AND INACTIVE CONFORMATIONS SUGGESTS A MECHANISM OF ACTIVATION FOR TEC FAMILY KINASES. |
3OCS | A:402-651 | CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746 |
3OCT | A:402-651 | CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB |
3P08 | B:402-651; B:402-651 | CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN |
3PIX | A:402-651 | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7-(4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H-PHTHALAZIN-1-ONE |
3PIY | A:402-651 | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406 |
3PIZ | A:402-651 | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O-TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]-METHANONE |
3PJ1 | A:402-651 | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE |
3PJ2 | A:402-651 | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
3PJ3 | A:402-651 | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)-(3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-BENZAMIDE |
2OGV | A:582-910 | CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN |
3LCD | A:582-910 | INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R |
3LCO | A:582-910 | INHIBITOR BOUND TO A DFG-OUT STRUCTURE OF THE KINASE DOMAIN OF CSF-1R |
1M14 | A:688-944 | TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR |
1M17 | A:688-944 | EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB |
1XKK | A:712-968 | EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016 |
1Z9I | A:44-53 | A STRUCTURAL MODEL FOR THE MEMBRANE-BOUND FORM OF THE JUXTAMEMBRANE DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR |
2JIT | B:712-968; B:712-968 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION |
2JIU | B:712-968; B:712-968 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788 |
2JIV | B:712-968; B:712-968 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272 |
2RF9 | B:688-944; B:688-944 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
2RFD | B:688-944; B:688-944 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
2RFE | D:688-944; D:688-944; D:688-944; D:688-944 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
2RGP | A:712-968 | STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR |
3LZB | D:688-944; D:688-944; D:688-944; D:688-944 | EGFR KINASE DOMAIN COMPLEXED WITH AN IMIDAZO[2,1-B]THIAZOLE INHIBITOR |
3POZ | A:712-968 | EGFR KINASE DOMAIN COMPLEXED WITH TAK-285 |
1MQB | B:613-871; B:613-871 | CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE |
2QO2 | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE |
2QO7 | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND |
2QO9 | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND |
2QOB | A:621-878 | HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE |
2QOC | A:621-878 | HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE |
2QOD | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT |
2QOF | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT |
2QOK | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT |
2QON | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT |
2QOO | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT |
2QOQ | A:621-878 | HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE |
2R2P | A:675-932 | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5) |
2REI | A:633-890 | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) |
3KUL | B:635-892; B:635-892 | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8) |
2VWU | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2VWV | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2VWW | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2VWX | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2VWZ | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2VX0 | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2VX1 | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2X9F | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
2XVD | A:615-874 | EPHB4 KINASE DOMAIN INHIBITOR COMPLEX |
3PP0 | B:720-976; B:720-976 | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2). |
3KEX | B:690-946; B:690-946 | CRYSTAL STRUCTURE OF THE CATALYTICALLY INACTIVE KINASE DOMAIN OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |
3LMG | B:690-946; B:690-946 | CRYSTAL STRUCTURE OF THE ERBB3 KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
2R4B | B:718-974; B:718-974 | ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR |
1MP8 | A:422-676 | CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK) |
3JS2 | B:478-754; B:478-754 | CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID |
3KXX | D:478-754; D:478-754; D:478-754; D:478-754 | STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1 |
3KY2 | B:478-754; B:478-754 | CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN |
3RHX | B:478-754; B:478-754 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069 |
1OEC | A:481-757 | FGFR2 KINASE DOMAIN |
2PSQ | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN |
2PVF | A:481-757 | CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE |
2PVY | D:481-757; D:481-757; D:481-757; D:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME. |
2PWL | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME. |
2PY3 | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
2PZ5 | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
2PZP | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME |
2PZR | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
2Q0B | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME |
3RI1 | B:481-757; B:481-757 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069 |
1RJB | A:610-943 | CRYSTAL STRUCTURE OF FLT3 |
1QCF | A:267-516 | CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR |
1JQH | C:999-1266; C:999-1266; C:999-1266 | IGF-1 RECEPTOR KINASE DOMAIN |
1K3A | A:969-1236 | STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE |
1M7N | B:996-1263; B:996-1263 | CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN |
1P4O | B:969-1236; B:969-1236 | STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION. |
2OJ9 | A:969-1236 | STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR |
2ZM3 | D:999-1266; D:999-1266; D:999-1266; D:999-1266 | COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR |
3LVP | D:999-1266; D:999-1266; D:999-1266; D:999-1266 | CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR |
3LW0 | D:999-1266; D:999-1266; D:999-1266; D:999-1266 | IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1 |
3NW5 | A:969-1236 | CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11B) |
3NW6 | A:969-1236 | CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11A) |
3NW7 | A:969-1236 | CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (34) |
3O23 | A:999-1266 | HUMAN UNPHOSPHORYLATED IGF1-R KINASE DOMAIN IN COMPLEX WITH AN HYDANTOIN INHIBITOR |
3QQU | D:996-1263; D:996-1263; D:996-1263; D:996-1263 | COCRYSTAL STRUCTURE OF UNPHOSPHORYLATED IGF WITH PYRIMIDINE 8 |
3KMU | A:193-446 | CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (APO) |
3KMW | A:193-446 | CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MGATP) |
3REP | A:193-446 | CRYSTAL STRUCTURE OF THE ILK/ALPHA-PARVIN CORE COMPLEX (MNATP) |
1P14 | A:996-1263 | CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE |
1RQQ | B:996-1263; B:996-1263 | CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS |
2Z8C | A:996-1263 | PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2-YL]AMINO}PHENYL)ACETIC ACID |
1SM2 | B:363-612; B:363-612 | CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN |
1SNU | B:363-612; B:363-612 | CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN |
1SNX | B:363-612; B:363-612 | CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN |
3MIY | B:363-612; B:363-612 | X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB |
3MJ1 | A:363-612 | X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR RO5191614 |
3MJ2 | A:363-612 | X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BMS-509744 |
3QGW | B:363-612; B:363-612 | CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR |
3QGY | B:363-612; B:363-612 | CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX |
2W1I | B:849-1123; B:849-1123 | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
2XA4 | B:849-1123; B:849-1123 | INHIBITORS OF JAK2 KINASE DOMAIN |
3JY9 | A:849-1123 | JANUS KINASE 2 INHIBITORS |
3KCK | A:849-1123 | A NOVEL CHEMOTYPE OF KINASE INHIBITORS |
3KRR | A:849-1123 | CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT QUINOXALINE ATP SITE INHIBITOR |
3LPB | B:849-1123; B:849-1123 | CRYSTAL STRUCTURE OF JAK2 COMPLEXED WITH A POTENT 2,8-DIARYL-QUINOXALINE INHIBITOR |
3Q32 | B:849-1123; B:849-1123 | STRUCTURE OF JANUS KINASE 2 WITH A PYRROLOTRIAZINE INHIBITOR |
1YVJ | A:822-1095 | CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE |
3LXK | A:822-1095 | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
3LXL | A:822-1095 | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
3PJC | A:822-1095 | CRYSTAL STRUCTURE OF JAK3 COMPLEXED WITH A POTENT ATP SITE INHIBITOR SHOWING HIGH SELECTIVITY WITHIN THE JANUS KINASE FAMILY |
1PKG | B:589-924; B:589-924 | STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX |
1T46 | A:589-924 | STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE |
2Y4I | B:666-928 | KSR2-MEK1 HETERODIMER |
1XBA | A:371-626 | CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN |
1QPC | A:245-494 | STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS |
1QPD | A:245-494 | STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS |
1QPE | A:245-494 | STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS |
1QPJ | A:245-494 | CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE. |
2OF2 | A:245-494 | CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK |
2OF4 | A:245-494 | CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK |
2OFU | A:245-494 | X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK |
2OFV | B:245-494; B:245-494 | CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK |
2OG8 | B:245-494; B:245-494 | CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK |
2PL0 | A:245-494 | LCK BOUND TO IMATINIB |
2ZM1 | A:245-494 | CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
2ZM4 | A:245-494 | CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) |
2ZYB | A:245-494 | CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394) |
3KMM | A:245-494 | STRUCTURE OF HUMAN LCK KINASE WITH A SMALL MOLECULE INHIBITOR |
3LCK | A:245-494 | THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) |
3MPM | A:245-494 | LCK COMPLEXED WITH A PYRAZOLOPYRIMIDINE |
3S95 | B:339-604; B:339-604 | CRYSTAL STRUCTURE OF THE HUMAN LIMK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE |
2P0C | B:587-854; B:587-854 | CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER |
1R0P | A:1078-1337 | CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A |
2RFN | B:1078-1337; B:1078-1337 | X-RAY STRUCTURE OF C-MET WITH INHIBITOR. |
2RFS | A:1078-1337 | X-RAY STRUCTURE OF SU11274 BOUND TO C-MET |
2WGJ | A:1078-1337 | X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET |
2WKM | A:1078-1337 | X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET |
3LQ8 | A:1078-1337 | STRUCTURE OF THE KINASE DOMAIN OF C-MET BOUND TO XL880 (GSK1363089) |
3Q6U | A:1078-1337 | STRUCTURE OF THE APO MET RECEPTOR KINASE IN THE DUALLY-PHOSPHORYLATED, ACTIVATED STATE |
3Q6W | A:1078-1337 | STRUCTURE OF DUALLY-PHOSPHORYLATED MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG WITH SPECIFICITY FOR THE ACTIVATED RECEPTOR |
3QTI | B:1078-1337; B:1078-1337 | C-MET KINASE IN COMPLEX WITH NVP-BVU972 |
3RHK | B:1078-1337; B:1078-1337 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197 |
3PYY | B:261-512; B:261-512 | DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE |
3OG7 | B:457-714; B:457-714 | B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032 |
3OMV | B:349-606; B:349-606 | CRYSTAL STRUCTURE OF C-RAF (RAF-1) |
2X2K | A:724-1005 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
2X2L | A:724-1005 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
2X2M | B:724-1005; B:724-1005 | CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR |
3PLS | A:1082-1341 | RON IN COMPLEX WITH LIGAND AMP-PNP |
1KSW | A:267-516 | STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP |
1Y57 | A:267-516 | STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR |
1YI6 | B:267-516; B:267-516 | C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533) |
1YOJ | B:271-518; B:271-518 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN |
1YOL | B:269-518; B:269-518 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675 |
1YOM | B:269-518; B:269-518 | CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A |
2SRC | A:267-516 | CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP |
2OO8 | X:836-1092 | SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS |
2OSC | A:837-1092 | SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS |
2P4I | B:836-1092; B:836-1092 | EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR |
2WQB | A:824-1092 | STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR |
3L8P | A:824-1092 | CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207 |
3LXN | A:897-1169 | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
3LXP | A:897-1169 | STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 |
3NYX | A:897-1169 | NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZOLE-THIOPHENE INHIBITOR |
3NZ0 | A:897-1169 | NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6 |
1VR2 | A:834-1160 | HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN |
1Y6A | A:832-1158 | CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR |
1Y6B | A:832-1158 | CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR |
1YWN | A:832-1158 | VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE |
2OH4 | A:832-1158 | CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR |
2P2H | A:834-1160 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR |
2QU5 | A:834-1160 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR |
2QU6 | B:834-1160; B:834-1160 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR |
2XIR | A:834-1160 | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH PF-00337210 (N,2-DIMETHYL-6-(7-(2-MORPHOLINOETHOXY) QUINOLIN-4-YLOXY)BENZOFURAN-3-CARBOXAMIDE) |
1U59 | A:338-593 | CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE |
2OZO | A:338-593 | AUTOINHIBITED INTACT HUMAN ZAP-70 |